Inhaled nitric oxide for neonates with persistent pulmonary hypertension of the newborn in the CINRGI study: time to treatment response
Abstract Background Substantial numbers of neonates with hypoxic respiratory failure (HRF) do not immediately respond to inhaled nitric oxide (iNO) and are often labeled as non-responders. This retrospective data analysis assessed time to treatment response in the iNO key registration trial. Methods...
Main Authors: | Leif D. Nelin, Jim L. Potenziano |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-01-01
|
Series: | BMC Pediatrics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12887-018-1368-4 |
Similar Items
-
Beyond the inhaled nitric oxide in persistent pulmonary hypertension of the newborn
by: Mei-Yin Lai, et al.
Published: (2018-02-01) -
The Controversy Persists: Is There a Qualification Criterion to Utilize Inhaled Nitric Oxide in Pre-term Newborns?
by: Frederico Vieira, et al.
Published: (2021-03-01) -
Inhaled iloprost as part of combination therapy for persistent pulmonary hypertension of the newborn
by: Heru Samudro, et al.
Published: (2012-03-01) -
Asphyxia and Neonatal Respiratory Distress Syndrome Are Independent Predictors of the Non-response to Inhaled Nitric Oxide in the Newborns With PPHN
by: Yuwei Zhao, et al.
Published: (2021-05-01) -
Inhaled Nitric Oxide at Birth Reduces Pulmonary Vascular Resistance and Improves Oxygenation in Preterm Lambs
by: Satyan Lakshminrusimha, et al.
Published: (2021-05-01)